![](https://endpts.com/wp-content/uploads/2020/06/Ashleigh-Palmer-tile-youtube-1-scaled.jpg)
Ashleigh Palmer, Provention Bio CEO
Provention Bio takes a $125M loan to advance Eli Lilly’s once-rejected diabetes drug
Amidst the ongoing biotech market slowdown, companies are trying various ways to stay afloat. Some are going public, and some are taking on debt. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.